Publication | Open Access
An Open-label Phase I/IIa Clinical Trial of 11β-HSD1 Inhibitor for Cushing’s Syndrome and Autonomous Cortisol Secretion
30
Citations
49
References
2021
Year
S-707106 is an effective insulin sensitizer and antisarcopenic and antiobesity medication for these patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1